CareLink Personal Software Therapy Management Software Tool for Diabetes CareLink System Therapy...

FDA Device Recall #Z-0843-2021 — Class II — November 12, 2020

Recall Summary

Recall Number Z-0843-2021
Classification Class II — Moderate risk
Date Initiated November 12, 2020
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic Inc.
Location Northridge, CA
Product Type Devices
Quantity 46,461 affected systems

Product Description

CareLink Personal Software Therapy Management Software Tool for Diabetes CareLink System Therapy Management Software Tool for Diabetes Software Uploader versions: 3.1.5.000 3.1.2.000

Reason for Recall

Incomplete basal rate information may be transmitted leading to a potential for inappropriate change in therapy. During data upload, radio frequency (RF) interference can occur at any point from surrounding devices or equipment that may affect the data transfer between the insulin pump and the CareLink Personal or CareLink System Software.

Distribution Pattern

U.S. Nationwide O.U.S. Worldwide Refer to Associated Documents and uploaded Consignee Lists/Spreadsheets. -Australia New Zealand -Canada -EMEA -Greater China -India -Japan -Latin America -South Korea -Southeast Asia -US

Lot / Code Information

CareLinkTM Personal (MMT-7333) using CareLink Uploader (ACC-7350) UDI (GTIN/UPN): 00763000424121 CareLinkTM system (MMT-7350) using CareLink Uploader (ACC-7350) UDI (GTIN/UPN): 00763000424138

Other Recalls from Medtronic Inc.

Recall # Classification Product Date
Z-3152-2024 Class II 2090 Programmers with serial number prefixes PK... Jul 11, 2024
Z-2197-2024 Class II EVERA MRI S VR SureScan, Model Number DVMC3D4, ... Apr 16, 2024
Z-2206-2024 Class II COBALT DR MRI SureScan, Model Number DDPB3D1, I... Apr 16, 2024
Z-2190-2024 Class II COBALT HF QUAD CRT-D MRI SureScan, Model Number... Apr 16, 2024
Z-2210-2024 Class II COBALT XT VR MRI SureScan, Model Number DVPA2D1... Apr 16, 2024

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.